Helminthic therapy: Using worms to treat immune-mediated disease

57Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There is an epidemic of immune-mediated disease in highly-developed industrialized countries. Such diseases, like inflammatory bowel disease, multiple sclerosis and asthma increase in prevalence as populations adopt modern hygienic practices. These practices prevent exposure to parasitic worms (helminths). Epidemiologic studies suggest that people who carry helminths have lessimmune-mediated disease. Mice colonized with helminths are protected from disease in models ofcolitis, encephalitis, Type 1 diabetes and asthma. Clinical trials show that exposure to helminths reduce disease activity in patients with ulcerative colitis or Crohn's disease. This chapter reviews some of the work showing that colonization with helminths alters immune responses, against dysregulared inflammation. These helminth-host immune interactions have potentially important implications for the treatment ofimmune-mediated disea ses. © 2009 Landes Bioscience and Springer Science+Business Media.

Cite

CITATION STYLE

APA

Elliott, D. E., & Weinstock, J. V. (2009). Helminthic therapy: Using worms to treat immune-mediated disease. Advances in Experimental Medicine and Biology, 666, 157–166. https://doi.org/10.1007/978-1-4419-1601-3_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free